Copyright: ©Author(s) 2026.
World J Clin Oncol. May 24, 2026; 17(5): 118265
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.118265
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.118265
Table 1 Comparison of baseline data between two cohorts, mean ± SD/n (%)
| Cohort A (n = 185) | Cohort B (n = 314) | t/χ2 | P value | |
| Age | 62.47 ± 11.30 | 58.51 ± 10.33 | 3.89 | < 0.01a |
| Gender | 0.60 | 0.44 | ||
| Male | 106 (57.30) | 191 (60.83) | ||
| Female | 79 (42.70) | 123 (39.17) | ||
| Primary site | 0.08 | 0.78 | ||
| Right-side colon | 57 (30.81) | 93 (29.62) | ||
| Left-side colon | 128 (69.19) | 221 (70.38) | ||
| Local treatment of liver metastases1 | 40.60 | < 0.01a | ||
| Yes | 66 (35.68) | 204 (64.97) | ||
| No | 119 (64.32) | 110 (35.03) | ||
| Gene type | 0.81 | 0.67 | ||
| RAS/BRAF wild type | 83 (44.86) | 141 (44.90) | ||
| RAS/BRAF mutation | 87 (47.03) | 154 (49.04) | ||
| No genetic testing | 15 (8.11) | 19 (6.05) | ||
| Site of metastasis | 0.13 | 0.72 | ||
| Liver metastasis only | 73 (39.46) | 129 (41.08) | ||
| Combined with extrahepatic metastasis | 112 (60.54) | 185 (58.92) |
- Citation: Bian JY, Sun YX, Wang LF, He WT, Liu CB, Wang XQ, Zhang T. Integrated Chinese and Western medicine prolong survival in colorectal cancer with liver metastasis: A retrospective cohort study. World J Clin Oncol 2026; 17(5): 118265
- URL: https://www.wjgnet.com/2218-4333/full/v17/i5/118265.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i5.118265